1 / 25

Giving Birth to a Biotech: Where's the Pain Relief?!

Dr. Caroline Barelle MBA, PhD, BSc Biochem, discusses the challenges and process of establishing a biotech company. From conception to birth, learn about the investment, development, and labor involved in the biotech industry. Discover the potential for early revenues and the importance of a strong team and external support.

callahan
Download Presentation

Giving Birth to a Biotech: Where's the Pain Relief?!

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Giving birth to a biotech........where’s the pain relief ?! Dr Caroline Barelle MBA

  2. Fibrinolysis - PhD BSc Biochem University

  3. Medical mycology Academia University

  4. PI Academia University

  5. Biotech Academia University

  6. Stop Press………October 2007 Wyeth acquires Haptogen

  7. From the ocean to the clinic……………..

  8. Biotech Pharma Academia University

  9. A shot from the blue………………..

  10. The biggest Pharma Biotech Pharma Academia University

  11. The biggest Pharma Biotech ? Pharma Academia University

  12. The biggest Pharma Biotech Asset portfolio IP/domains Pharma Academia University

  13. The biggest Pharma Biotech Investment Pharma Academia University

  14. Pushmi-Pullyu/Need-Desire………………

  15. The Business of Biotech……………… Takes a long time and a lot of money

  16. The Model……………… • Medical devices, • Clinical Diagnostics, • Lower risk, lower return • Potential for early revenues • Exit often trade-sale • Drug discovery • High risk • Makes nothing, sells nothing • 99% chance of failure • Consumes loads of cash • Returns are staggering if successful

  17. The Model……………… • Medical devices, • Clinical Diagnostics, • Lower risk, lower return • Potential for early revenues • Exit often trade-sale • Drug discovery • High risk • Makes nothing, sells nothing • 99% chance of failure • Consumes loads of cash • Returns are staggering if successful

  18. Money, money, money……………….. Seed Series A Series B Series C

  19. The Process………………

  20. The Conception………………..

  21. The Development……………….. Reporting Conferences Milestones Collaborations CROs Meetings Science Value build Investor ready Value proposition Commercial Investors Customers Consultants BP IP Secure seed/series A

  22. The Labour……………….. • Lead the Science • Operations • Business Development • Commercialisation/Corporate • Alliance management • Reports • Due Diligence • IP • Papers • Conferences • BioPartnering • Budget

  23. The Birth……………….. • Articles of association • Shareholding • Legal • Employee contracts • Facilities • Finance • IP • Consultants • SAB • Chair • Directors • NEDs • Marketing • Website • HR • Organizational Development • Press The next tranche of cash!

  24. The Pain Relief……………….. • A good team • External support • Be realistic • Enjoy

  25. Questions??

More Related